Knowledge Distillery

This randomized, double-blind, placebo-controlled phase 2 clinical trial investigated the potential therapeutic value of losartan, an angiotensin II…

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

In this research letter recently published in JAMA, the authors assessed persistent symptoms in patients who had been discharged from hospital after…

Impact of coronavirus disease 2019 in a French cohort of myasthenia gravis

The objective of this double-blind randomised controlled trial was to compare propranolol and topiramate in terms of tolerability and efficacy in…

Immunological characteristics govern the transition of COVID-19 to endemicity

Anosmia, stroke, paralysis, cranial nerve deficits, encephalopathy, delirium, meningitis, and seizures are some of the neurological complications in…

Increased worsening of amyotrophic lateral sclerosis patients during COVID-19-related lockdown in France

Safe, effective vaccines against coronavirus disease 2019 (COVID-19) are urgently needed in children younger than 12 years of age. In this article the…

Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape

In this study, recently published in Brain, the authors present cerebrovascular disease case incidence in hospitalised patients with SARS-CoV-2…

COVID-19 and disease-modifying therapies in patients with demyelinating diseases of the central nervous system: A systematic review